Myovant Sciences
(NYSE) MYOV
This security has been delisted. This page is retained for historical reference.
MYOV News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowMYOV Financials
Key Financial Metrics (TTM)
Gross Margin
77.68%
Operating Margin
-81.11%
Net Income Margin
-89.18%
Return on Equity
49.79%
Return on Capital
N/A
Return on Assets
-39.61%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$276.85M
Operating Income
-$146.91M
EBITDA
-$140.43M
Operating Cash Flow
-$269.87M
Capital Expenditure
-$865.00K
Free Cash Flow
-$270.73M
Cash & ST Invst.
$274.44M
Total Debt
$366.88M
Myovant Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$100.23M
+84.1%
Gross Profit
$66.00M
+73.2%
Gross Margin
65.85%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
579
N/A
Net Income
-$57.63M
+9.2%
EBITDA
-$49.42M
+16.1%
Quarterly Fundamentals
Total Cash
$274.44M
-48.0%
Total Debt
$366.88M
-0.4%
Accounts Receivable
$41.02M
+116.9%
Inventory
$30.08M
+346.5%
Long Term Debt
$364.18M
-0.6%
Short Term Debt
$2.70M
+31.7%
Return on Assets
-39.61%
N/A
Return on Invested Capital
-69.47%
N/A
Free Cash Flow
-$103.13M
-11.8%
Operating Cash Flow
-$102.90M
-12.0%